With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Find a program. Start typing and choose from the list below. Watch all your favourite ABC programs on ABC iview. More from ABC We acknowledge Aboriginal and Torres Strait Islander peoples as the First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results